The global Bacteriophage market size was valued at US$ 53.9 million in 2024 and is forecast to a readjusted size of USD 178 million by 2031 with a CAGR of 18.8% during review period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.
This report is a detailed and comprehensive analysis for global Bacteriophage market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bacteriophage market size and forecasts, in consumption value ($ Million), 2020-2031
Global Bacteriophage market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Bacteriophage market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Bacteriophage market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bacteriophage
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bacteriophage market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Bacteriophage market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
麻豆原创 segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
麻豆原创 segment by players, this report covers
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bacteriophage product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bacteriophage, with revenue, gross margin, and global market share of Bacteriophage from 2020 to 2025.
Chapter 3, the Bacteriophage competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Bacteriophage market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bacteriophage.
Chapter 13, to describe Bacteriophage research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Bacteriophage by Type
1.3.1 Overview: Global Bacteriophage 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Bacteriophage Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 DsDNA Bacteriophage
1.3.4 SsDNA Bacteriophage
1.3.5 SsRNA Bacteriophage
1.3.6 Others
1.4 Global Bacteriophage 麻豆原创 by Application
1.4.1 Overview: Global Bacteriophage 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Animal Health
1.4.3 Aquaculture
1.4.4 Agriculture
1.4.5 Food Industry
1.4.6 Human Health
1.4.7 Others
1.5 Global Bacteriophage 麻豆原创 Size & Forecast
1.6 Global Bacteriophage 麻豆原创 Size and Forecast by Region
1.6.1 Global Bacteriophage 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Bacteriophage 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Bacteriophage 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Bacteriophage 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Bacteriophage 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Bacteriophage 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Bacteriophage 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 NPO Microgen
2.1.1 NPO Microgen Details
2.1.2 NPO Microgen Major Business
2.1.3 NPO Microgen Bacteriophage Product and Solutions
2.1.4 NPO Microgen Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 NPO Microgen Recent Developments and Future Plans
2.2 Qingdao Phagepharm Bio-tech
2.2.1 Qingdao Phagepharm Bio-tech Details
2.2.2 Qingdao Phagepharm Bio-tech Major Business
2.2.3 Qingdao Phagepharm Bio-tech Bacteriophage Product and Solutions
2.2.4 Qingdao Phagepharm Bio-tech Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Qingdao Phagepharm Bio-tech Recent Developments and Future Plans
2.3 Armata Pharmaceuticals, Inc.
2.3.1 Armata Pharmaceuticals, Inc. Details
2.3.2 Armata Pharmaceuticals, Inc. Major Business
2.3.3 Armata Pharmaceuticals, Inc. Bacteriophage Product and Solutions
2.3.4 Armata Pharmaceuticals, Inc. Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
2.4 Phaxiam Therapeutics
2.4.1 Phaxiam Therapeutics Details
2.4.2 Phaxiam Therapeutics Major Business
2.4.3 Phaxiam Therapeutics Bacteriophage Product and Solutions
2.4.4 Phaxiam Therapeutics Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Phaxiam Therapeutics Recent Developments and Future Plans
2.5 Eliava BioPreparations
2.5.1 Eliava BioPreparations Details
2.5.2 Eliava BioPreparations Major Business
2.5.3 Eliava BioPreparations Bacteriophage Product and Solutions
2.5.4 Eliava BioPreparations Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Eliava BioPreparations Recent Developments and Future Plans
2.6 Intralytix
2.6.1 Intralytix Details
2.6.2 Intralytix Major Business
2.6.3 Intralytix Bacteriophage Product and Solutions
2.6.4 Intralytix Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Intralytix Recent Developments and Future Plans
2.7 MicroMir
2.7.1 MicroMir Details
2.7.2 MicroMir Major Business
2.7.3 MicroMir Bacteriophage Product and Solutions
2.7.4 MicroMir Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 MicroMir Recent Developments and Future Plans
2.8 Phagelux
2.8.1 Phagelux Details
2.8.2 Phagelux Major Business
2.8.3 Phagelux Bacteriophage Product and Solutions
2.8.4 Phagelux Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Phagelux Recent Developments and Future Plans
2.9 Pharmex Group, LLC
2.9.1 Pharmex Group, LLC Details
2.9.2 Pharmex Group, LLC Major Business
2.9.3 Pharmex Group, LLC Bacteriophage Product and Solutions
2.9.4 Pharmex Group, LLC Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Pharmex Group, LLC Recent Developments and Future Plans
2.10 APS Biocontrol Ltd. (APS)
2.10.1 APS Biocontrol Ltd. (APS) Details
2.10.2 APS Biocontrol Ltd. (APS) Major Business
2.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Product and Solutions
2.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 APS Biocontrol Ltd. (APS) Recent Developments and Future Plans
2.11 ACD Pharma
2.11.1 ACD Pharma Details
2.11.2 ACD Pharma Major Business
2.11.3 ACD Pharma Bacteriophage Product and Solutions
2.11.4 ACD Pharma Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 ACD Pharma Recent Developments and Future Plans
2.12 Proteon Pharmaceuticals
2.12.1 Proteon Pharmaceuticals Details
2.12.2 Proteon Pharmaceuticals Major Business
2.12.3 Proteon Pharmaceuticals Bacteriophage Product and Solutions
2.12.4 Proteon Pharmaceuticals Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Proteon Pharmaceuticals Recent Developments and Future Plans
2.13 Micreos
2.13.1 Micreos Details
2.13.2 Micreos Major Business
2.13.3 Micreos Bacteriophage Product and Solutions
2.13.4 Micreos Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Micreos Recent Developments and Future Plans
2.14 Locus Biosciences, Inc
2.14.1 Locus Biosciences, Inc Details
2.14.2 Locus Biosciences, Inc Major Business
2.14.3 Locus Biosciences, Inc Bacteriophage Product and Solutions
2.14.4 Locus Biosciences, Inc Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Locus Biosciences, Inc Recent Developments and Future Plans
2.15 NexaBiome Limited
2.15.1 NexaBiome Limited Details
2.15.2 NexaBiome Limited Major Business
2.15.3 NexaBiome Limited Bacteriophage Product and Solutions
2.15.4 NexaBiome Limited Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 NexaBiome Limited Recent Developments and Future Plans
2.16 PhagePro
2.16.1 PhagePro Details
2.16.2 PhagePro Major Business
2.16.3 PhagePro Bacteriophage Product and Solutions
2.16.4 PhagePro Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 PhagePro Recent Developments and Future Plans
2.17 BiomX
2.17.1 BiomX Details
2.17.2 BiomX Major Business
2.17.3 BiomX Bacteriophage Product and Solutions
2.17.4 BiomX Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 BiomX Recent Developments and Future Plans
2.18 INtODEWORLD, Inc.
2.18.1 INtODEWORLD, Inc. Details
2.18.2 INtODEWORLD, Inc. Major Business
2.18.3 INtODEWORLD, Inc. Bacteriophage Product and Solutions
2.18.4 INtODEWORLD, Inc. Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 INtODEWORLD, Inc. Recent Developments and Future Plans
2.19 TechnoPhage
2.19.1 TechnoPhage Details
2.19.2 TechnoPhage Major Business
2.19.3 TechnoPhage Bacteriophage Product and Solutions
2.19.4 TechnoPhage Bacteriophage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 TechnoPhage Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Bacteriophage Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Bacteriophage by Company Revenue
3.2.2 Top 3 Bacteriophage Players 麻豆原创 Share in 2024
3.2.3 Top 6 Bacteriophage Players 麻豆原创 Share in 2024
3.3 Bacteriophage 麻豆原创: Overall Company Footprint Analysis
3.3.1 Bacteriophage 麻豆原创: Region Footprint
3.3.2 Bacteriophage 麻豆原创: Company Product Type Footprint
3.3.3 Bacteriophage 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Bacteriophage Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Bacteriophage 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Bacteriophage Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Bacteriophage 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Bacteriophage Consumption Value by Type (2020-2031)
6.2 North America Bacteriophage 麻豆原创 Size by Application (2020-2031)
6.3 North America Bacteriophage 麻豆原创 Size by Country
6.3.1 North America Bacteriophage Consumption Value by Country (2020-2031)
6.3.2 United States Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Bacteriophage Consumption Value by Type (2020-2031)
7.2 Europe Bacteriophage Consumption Value by Application (2020-2031)
7.3 Europe Bacteriophage 麻豆原创 Size by Country
7.3.1 Europe Bacteriophage Consumption Value by Country (2020-2031)
7.3.2 Germany Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Bacteriophage Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Bacteriophage 麻豆原创 Size by Region
8.3.1 Asia-Pacific Bacteriophage Consumption Value by Region (2020-2031)
8.3.2 China Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Bacteriophage Consumption Value by Type (2020-2031)
9.2 South America Bacteriophage Consumption Value by Application (2020-2031)
9.3 South America Bacteriophage 麻豆原创 Size by Country
9.3.1 South America Bacteriophage Consumption Value by Country (2020-2031)
9.3.2 Brazil Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Bacteriophage Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Bacteriophage 麻豆原创 Size by Country
10.3.1 Middle East & Africa Bacteriophage Consumption Value by Country (2020-2031)
10.3.2 Turkey Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Bacteriophage 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Bacteriophage 麻豆原创 Drivers
11.2 Bacteriophage 麻豆原创 Restraints
11.3 Bacteriophage Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Bacteriophage Industry Chain
12.2 Bacteriophage Upstream Analysis
12.3 Bacteriophage Midstream Analysis
12.4 Bacteriophage Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
听
听
*If Applicable.
